sk&f 81297 has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vermeulen, RJ | 2 |
| Drukarch, B | 2 |
| Sahadat, MC | 1 |
| Goosen, C | 1 |
| Wolters, EC | 1 |
| Stoof, JC | 2 |
| Andringa, G | 1 |
| Renier, WO | 1 |
| Cools, AR | 1 |
2 other studies available for sk&f 81297 and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.
Topics: Analysis of Variance; Animals; Benzazepines; Disease Models, Animal; Dopamine Agents; Ergolines; Mac | 1993 |
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.
Topics: Animals; Arm; Behavior, Animal; Benzazepines; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; | 1999 |